MARKET WIRE NEWS

Outperform Recommendation Issued On MNPR By Oppenheimer

Source: KlickAnalytics

2025-10-02 10:15:13 ET

  • Oppenheimer analyst issues OUTPERFORM recommendation for MNPR on October 2, 2025 11:50AM ET.
  • The previous analyst recommendation was Outperform.
  • MNPR was trading at $92.18 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 9 - Buy, 2 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations< ...
    Full story available on KlickAnalytics.com
    Monopar Therapeutics Inc.

    NASDAQ: MNPR

    MNPR Trading

    5.23% G/L:

    $59.47 Last:

    49,481 Volume:

    $57.82 Open:

    mwn-link-x Ad 300

    MNPR Latest News

    MNPR Stock Data

    $384,114,928
    4,169,932
    0.03%
    12
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    Wilmette

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App